Sir, The beneficial, long-lasting local effect of triamcinolone hexacetonide versus other intra-articularly administered steroids is explained by the very low solubility of the drug in synovial fluid. Indeed, the low solubility of triamcinolone hexacetonide in water was demonstrated by Hollander." Accordingly one would expect systemic effects of this preparation to be minimal and their appearance to be delayed. We were therefore surprised at the results published by Bird et al. 2 showing early onset of systemic effects of intra-articular triamcinolone hexacetonide injections, slowly abating after 4 weeks.
We have studied 10 ambulatory patients with rheumatoid arthritis, none of them having received steroid treatment before. All patients had synovial fluid aspirated before receiving an intra-articular injection of 20 mg triamcinolone hexacetonide (Lederspan) in 1 ml in one affected knee, just as described in Bird's publication, who tested 10 of their patients with the same preparation. The only limitation imposed on our patients after injection was to reduce their physical activity for 24 h and to wear an elastic knee bandage for that period, modified from the customary advice after local yttrium-90 treatment.
We followed the systemic effects of the steriod injection on the pituitary-adrenal axis. Blood samples for plasma cortisol and ACTH were always taken at 10 am on the days indicated, and assayed by standard radioimmunoassay. Results see Table. Thus, contrary to the report by Bird et al., we found no early suppression of endogenous cortisol (corroborated by the results obtained with ACTH) Our finding of systemic effects of borderline significance on cortisol at 14 days fits the expected late effects due to low solubility of triamcinolone hexacetonide. One Plasma cortisol (pg/l00 ml) 12-5± 3-6 10-6±4-5 10-7+ 5-4 11-0± 3.1 9-5+ 3-1
11-7+4-8
All values are expressed as mean + SD. None of these differences were statistically significant, except cortisol day 0 versus day 14, which reaches borderline significance (t=2* 38; P=0 .05).
This letter has been shown to Dr Bird, whose reply follows.
Sir, In our study of intra-articular steroid preparations1 blood samples for plasma cortisol were taken at 10.30 a.m. ± 30 minutes and assayed in random order without knowledge of patients or drugs. The difference between our results and those of Dr Weiss et al. appears a real one, though the depression of endogenous cortisol we observed with triamcinolone hexacetonide was less than that seen with the 2 other preparations tested.
The hypothesis that splinting of the joint delays escape of exogenous steroid is the most attractive one. Our inpatients continued immediately with their physiotherapy and the outpatients were encouraged to exercise, instructions prompted by our failure to delay escape of intraarticular methotrexate with immobilisation in a previous study2 and our wish to simulate the majority of outpatient injection clinics. The suggestion that immobilisation delays escape of intra-articular steroid, not necessarily synonomous with increased therapeutic effect, has economic implications and should be possible to test now that high-pressure liquid chromatography has made exogenous steroid assays easier. Our demonstration of consistent thermographic improvement in the noninjected knees of triamcinolone-treated patients alone, in our double-blind study, remains unexplained. Neither study excludes a rapid leak of triamcinolone within the first 24 hours, though we agree that on theoretical grounds of insolubility3 this is unlikely.
While triamcinolone hexacetonide with immobilisation may be the steroid treatment of choice in rheumatoid synovitis of the knee, it must be emphasised that neither study was designed to determine whether the 'best' steroid, We have investigated 31 patients with SLE in regard to pulmonary involvement2 and found our results to be different from those in the above mentioned study. We observed respiratory symptoms only in 10 patients (32 %), whereas chest radiographs showed abnormalities in 21 patients (68%) ( Table 1) . We found concomitant obliteration of costophrenic angle and diaphragmatic elevation or segmental atelectasis and diaphragmatic elevation in 6 cases each.
Lung function analysis included spirography, plethysmography, measurement of diffusing capacity and of compliance (for details in methods see Schemthaner et al.3 The results are shown in Table 2 . Eight patients (26%) had normal results of lung function analysis. Seventeen patients showed restrictive ventilatory defects, 18 patients had a diminished lung compliance, and 12 patients had reduced diffusion capacity. In 9 of these patients restriction was observed in association with loss of compliance and reduced transfer factor, and in 5 patients restriction occurred together with decreased compliance. Restrictive defects alone were observed in 2 patients, disturbance of compliance alone in 4 patients, and reduced transfer factor in 2 patients. Restriction and loss of compliance showed the highest frequencies. 
